|Articles|May 1, 2001

Postmenopausal estrogen therapy and ovarian cancer

Small patient numbers, weak associations, plus the mixed story in the observational studies complicate accurate interpretation of the latest epidemiologic study on ERT.

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Subscribe

Related Content

SMFM in midst of first annual High-Risk Pregnancy Awareness Week

ByJoshua Fitch, Senior Editor

June 3rd 2026

Nearly 18 million US women aged 45 to 64 overdue for cancer screening, study finds

ByJoshua Fitch, Senior Editor

June 3rd 2026

Individualized TRT demonstrates broad symptom improvements beyond sexual function

ByMelissa Loseke, DO

June 2nd 2026

Acetaminophen remains first-line medication for pain, fever in pregnancy, SMFM says

ByJoshua Fitch, Senior Editor

June 1st 2026

FDA approves cefepime and zidebactam intravenous antibiotic to treat adults with cUTI

ByJoshua Fitch, Senior Editor

June 1st 2026

Latest CME

Video

Community Oncology Connections™: Clarifying Novel Treatment Pathways in HER2+ Breast Cancer – Washington

Alison K. Conlin, MD; Neil M. Iyengar, MD

Video

Community Oncology Connections™: Clarifying Novel Treatment Pathways in HER2+ Breast Cancer – Wyoming & Montana

Yan Ji, MD; Neil M. Iyengar, MD

Video

Community Oncology Connections™: Clarifying Novel Treatment Pathways in HER2+ Breast Cancer – North Carolina

Girish Kunapareddy, MD; Sara M. Tolaney, MD, MPH

Video

Addressing Healthcare Inequities: Detecting and Managing the Uncommon – Hemophilia in Women

Danielle Nance, MD; Kimberley Youkhana, MD

Postmenopausal estrogen therapy and ovarian cancer

Related Content

SMFM in midst of first annual High-Risk Pregnancy Awareness Week

Nearly 18 million US women aged 45 to 64 overdue for cancer screening, study finds

Individualized TRT demonstrates broad symptom improvements beyond sexual function

Acetaminophen remains first-line medication for pain, fever in pregnancy, SMFM says

FDA approves cefepime and zidebactam intravenous antibiotic to treat adults with cUTI

Latest CME

Community Oncology Connections™: Clarifying Novel Treatment Pathways in HER2+ Breast Cancer – Washington

Community Oncology Connections™: Clarifying Novel Treatment Pathways in HER2+ Breast Cancer – Wyoming & Montana

Community Oncology Connections™: Clarifying Novel Treatment Pathways in HER2+ Breast Cancer – North Carolina

Addressing Healthcare Inequities: Detecting and Managing the Uncommon – Hemophilia in Women

Trending on Contemporary OB/GYN

FDA approves cefepime and zidebactam intravenous antibiotic to treat adults with cUTI

Individualized TRT demonstrates broad symptom improvements beyond sexual function

Nearly 18 million US women aged 45 to 64 overdue for cancer screening, study finds

Acetaminophen remains first-line medication for pain, fever in pregnancy, SMFM says

Transdermal Hormone Therapy for VMS and Cardiovascular Risk Management